(lp0
S'BG Medicine: Nearing The Finish Line Seeking Alpha - Dec 3, 2015 When BG Medicine  went public nearly a half decade ago, it did so with much fanfare and hope for the future of its FDA approved Galectin-3 test to predict heart failure in individuals already diagnosed with the disease.'
p1
aS"Bounding Shares, What's Next for BG Medicine, Inc. ? Morgan Research - 13 hours ago BG Medicine, Inc.  are valued at $0.07 at the time of writing and have moved 0.00% since the open. Smart investors often look for value stocks with upside potential."
p2
aS'First Automated Test for Galectin-3 Now Available in US GlobeNewswire  - Jul 6, 2015 WALTHAM, Mass., July 6, 2015  -- BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today announced that the ARCHITECT Galectin-3 assay is now available.'
p3
aS'BG Medicine  Seeks Additional Indication from FDA for BGM Galectin-3 Test StreetInsider.com - Mar 31, 2015 BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today reported that it has filed a 510 Premarket Notification with U.S.'
p4
aS'BG Medicine  Stock Declines | Earnings Report Released CNA Finance  - Mar 31, 2015 BGMD Stock News BG Medicine, Inc.  BG Medicine stocks fell in a big way in morning trading today after the company released its earnings report before the bell.'
p5
aS'BG Medicine  Reports FDA Clearance of Automated Galectin-3 Testing  StreetInsider.com  - Dec 30, 2014 BG Medicine, Inc.   is the developer of the BGM Galectin-3 Test, which is the FDA-cleared manual microtiter plate version of the galectin-3 test, and the licensor of this first automated galectin-3 assay, which is used with ...'
p6
aS'In Volatile Markets Do Analysts Think You Should Buy BG Medicine, Inc. ? The De Soto Edge - Apr 13, 2017 11/13/2014 - BG Medicine, Inc. was downgraded to  by analysts at Ladenburg Thalmann. The share price of BG Medicine, Inc.  was down -17.65% during the last trading session, with a day high of 0.07. 1700 shares were traded on BG Medicine,&nbsp;...'
p7
aS'BG Medicine  Declines On Dilution Fears CNA Finance  - Aug 13, 2015 BG Medicine, Inc.  This morning, BG Medicine announced the price of an underwritten public offering of its equity securities; declining dramatically as investors fear dilution.'
p8
aS'BG Medicine  Galectin-3 Assigned Payment Code 82777 by CMS StreetInsider.com  - Nov 7, 2012 BG Medicine, Inc.  announcedthat the Centers for Medicare and Medicaid Services , in the Final Determination for the Medicare Clinical Laboratory Fee Schedule for 2013, assigned a payment rate for the BGM Galectin-3 test under&nbsp;...'
p9
aS'BG Medicine, Inc.  Receives An Update From Brokers The De Soto Edge - Apr 8, 2017 05/01/2015 - BG Medicine, Inc. had its  rating reiterated by analysts at Zacks. 11/13/2014 - BG Medicine, Inc. was downgraded to  by analysts at Ladenburg Thalmann. BG Medicine, Inc. has a 50 day moving average of 0.08 and a 200 day moving average&nbsp;...'
p10
a.